Cargando…

Successful treatment of pyrotinib for bone marrow metastasis induced pancytopenia in a patient with non‐small‐cell lung cancer and ERBB2 mutation

ERBB2 mutations are found in about 2% of patients with non‐small cell lung cancer (NSCLC). A recent study reported that pyrotinib (an irreversible pan ErbB inhibitor) had superior antitumor effect compared to other tyrosine kinase inhibitor therapies in patients with ERBB2 mutations. Bone marrow met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yanyan, Ni, Jun, Chang, Xiaoyan, Zhang, Xiaotong, Zhang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327666/ https://www.ncbi.nlm.nih.gov/pubmed/32458584 http://dx.doi.org/10.1111/1759-7714.13480

Ejemplares similares

Non‐small‐cell lung cancer with ERBB2 mutation in non‐tyrosine kinase domain benefits from pyrotinib: A case report
por: Ni, Jun, et al.
Publicado: (2021)

Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib–Irinotecan Combo: A Case Study
por: Ding, Kailin, et al.
Publicado: (2021)

Case Report: Efficacy of Pyrotinib in ERBB2 Amplification Pulmonary Adenoid Cystic Carcinoma
por: Tang, Zhongben, et al.
Publicado: (2021)

Pancytopenia with cellular bone marrow related to Graves’ hyperthyroidism
por: Raina, Sujeet, et al.
Publicado: (2012)

Erythroblastic Islands in the Bone Marrow of Patients with Immune-Related Pancytopenia
por: Wang, Yi-Hao, et al.
Publicado: (2014)

Bone Marrow and Karyotype Findings of Patients with Pancytopenia in Southern Iran
por: Safaei, Akbar, et al.
Publicado: (2014)

Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia
por: Erie, Andrew J., et al.
Publicado: (2010)

Bone Marrow Oxalosis in a Patient With Pancytopenia Following Bilateral Nephrectomy
por: Kim, Moon Jin, et al.
Publicado: (2016)

Correction: Erythroblastic Islands in the Bone Marrow of Patients with Immune-Related Pancytopenia
Publicado: (2014)

Increased Frequency of Bone Marrow T Follicular Helper Cells in Patients with Immune-Related Pancytopenia
por: Yu, Hong, et al.
Publicado: (2013)

HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib
por: Zhang, Xinyong, et al.
Publicado: (2020)

Efficacy and safety of pyrotinib and radiotherapy vs. pyrotinib-based therapy in patients with HER2(+) breast cancer with brain metastasis: a retrospective cohort study
por: Chen, Jiaxin, et al.
Publicado: (2022)

Histoplasmosis on bone marrow aspirate cytological examination associated with hemophagocytosis and pancytopenia in an AIDS patient
por: Chandra, Harish, et al.
Publicado: (2012)

Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report
por: Yang, Zi-yan, et al.
Publicado: (2020)

Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer
por: Wei, Xue‐Wu, et al.
Publicado: (2020)

Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer
por: Di Marino, Pietro, et al.
Publicado: (2022)

Germline ERBB3 mutation in familial non-small-cell lung carcinoma: expanding ErbB’s role in oncogenesis
por: McInerney-Leo, Aideen M, et al.
Publicado: (2021)

Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer
por: Wang, Xinfeng, et al.
Publicado: (2023)

A rare case of hepatoid carcinoma of the ovary with pancytopenia and hypocellular marrow
por: Lakhotia, Manoj, et al.
Publicado: (2016)

Demonstration of early functional compromise of bone marrow derived hematopoietic progenitor cells during bovine neonatal pancytopenia through in vitro culture of bone marrow biopsies
por: Laming, Eleanor, et al.
Publicado: (2012)

Bone marrow metastasis of small cell carcinoma of the lung mimicking Burkitt lymphoma/leukemias
por: Jung, Hye Ra, et al.
Publicado: (2011)

Case Report of an Adolescent Male With Unexplained Pancytopenia: GATA2-Associated Bone Marrow Failure and Genetic Testing
por: Azevedo, Lauren, et al.
Publicado: (2017)

Sulfasalazine-induced Pancytopenia Indicating Bone Marrow Suppression: A Rare Pediatric Case Report from Pakistan
por: Marsia, Shayan, et al.
Publicado: (2019)

First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient
por: Issa, N., et al.
Publicado: (2020)

A Spectrum of Hematological Disorders in Children with Pancytopenia Based on Bone Marrow Examination in a Tertiary Care Hospital
por: Zeeshan, Raana, et al.
Publicado: (2019)

Incremental low doses of amrubicin for the treatment of bone marrow metastasis in small cell lung cancer
por: Asai, Nobuhiro, et al.
Publicado: (2013)

Severe and Irreversible Pancytopenia Associated With SARS-CoV-2 Bone Marrow Infection in a Patient With Waldenstrom Macroglobulinemia
por: Velier, Mélanie, et al.
Publicado: (2021)

Extensive iron overload in bone marrow: A cause of pancytopenia in a thalassemia major patient – A case report
por: Ali, Maria, et al.
Publicado: (2020)

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial
por: Song, Zhengbo, et al.
Publicado: (2022)

Ataxia-pancytopenia syndrome with SAMD9L mutations
por: Gorcenco, Sorina, et al.
Publicado: (2017)

Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research
por: Cardillo, Anthony B., et al.
Publicado: (2023)

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation
por: Mao, Shiqi, et al.
Publicado: (2023)

Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma
por: Kilani, Yassine, et al.
Publicado: (2022)

Serum microRNA-365 suppresses non-small-cell lung cancer metastasis and invasion in patients with bone metastasis of lung cancer
por: Liu, Yanyan, et al.
Publicado: (2020)

Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
por: Wang, Hanping, et al.
Publicado: (2019)

Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib
por: Lian, Xiangyao, et al.
Publicado: (2020)

P110α inhibitor alpelisib exhibits a synergistic effect with pyrotinib and reverses pyrotinib resistant in HER2+ breast cancer
por: Chen, Hao, et al.
Publicado: (2023)

Pyrotinib plus antiangiogenic agents for HER2‐altered advanced non‐small cell lung cancer: A retrospective real‐world study
por: Yang, Yaning, et al.
Publicado: (2023)

Bone marrow involvement in small cell lung cancer
por: Loscocco, Giuseppe G., et al.
Publicado: (2021)

The efficacy and safety of pyrotinib in treating HER2‐positive breast cancer patients with brain metastasis: A multicenter study
por: Gao, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_omj7n8p1hesubnfsgbr55ukrkp